US Stock MarketDetailed Quotes

RNAC Cartesian Therapeutics

Watchlist
  • 19.800
  • -1.340-6.34%
Close Oct 31 16:00 ET
  • 19.800
  • 0.0000.00%
Post 16:20 ET
473.15MMarket Cap-419P/E (TTM)

Cartesian Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
537.17%33.45M
-1.65%5.84M
-76.53%26M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
30.21%110.78M
-43.90%16.8M
-15.22%20.71M
Operating revenue
537.17%33.45M
-1.65%5.84M
-76.53%26M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
30.21%110.78M
-43.90%16.8M
-15.22%20.71M
Cost of revenue
Gross profit
Operating expense
-17.58%19.69M
-21.10%19.19M
16.81%112.42M
76.34%44.6M
-12.07%19.62M
-6.00%23.89M
4.71%24.32M
7.32%96.24M
-2.20%25.29M
-15.48%22.31M
Selling and administrative expenses
15.10%7.03M
65.94%9.45M
70.07%40.58M
250.52%22.17M
14.63%6.61M
-2.02%6.11M
2.85%5.7M
13.97%23.86M
14.13%6.32M
5.97%5.77M
-General and administrative expense
15.10%7.03M
65.94%9.45M
70.07%40.58M
250.52%22.17M
14.63%6.61M
-2.02%6.11M
2.85%5.7M
13.97%23.86M
14.13%6.32M
5.97%5.77M
Research and development costs
-28.80%12.66M
-47.71%9.74M
-0.74%71.84M
18.26%22.43M
-21.39%13M
-7.30%17.78M
5.29%18.62M
5.30%72.38M
-6.65%18.97M
-21.06%16.54M
Operating profit
173.81%13.76M
27.38%-13.35M
-694.41%-86.42M
-327.64%-36.33M
-717.07%-13.07M
-234.47%-18.64M
-270.62%-18.38M
416.25%14.54M
-308.34%-8.5M
18.79%-1.6M
Net non-operating interest income expense
0
0
6.53%-2.83M
0
-58.73%-1.27M
-5.17%-752K
-14.29%-808K
-6.58%-3.03M
-13.50%-807K
-12.80%-802K
Non-operating interest expense
--0
--0
-6.53%2.83M
--0
58.73%1.27M
5.17%752K
14.29%808K
6.58%3.03M
13.50%807K
12.80%802K
Other net income (expense)
-99.01%79K
-1,657.32%-43.48M
-742.48%-149.46M
-1,175.44%-160.33M
191.79%5.34M
276.12%8M
-113.22%-2.47M
1,120.31%23.26M
65.46%14.91M
-1,046.74%-5.81M
Gain on sale of security
-134.97%-2.71M
-71.64%-4.68M
-674.94%-131.85M
-1,063.58%-141.96M
187.43%5.08M
270.73%7.76M
-114.71%-2.73M
1,099.26%22.93M
63.52%14.73M
-1,060.99%-5.81M
Special income (charges)
--2.5M
---39.3M
---18.3M
----
----
--0
--0
--0
----
----
-Less:Restructuring and merger&acquisition
---2.5M
--39.3M
--18.3M
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
19.18%292K
99.22%508K
109.39%691K
-135.43%-62K
25,200.00%253K
--245K
65.58%255K
2,100.00%330K
--175K
-88.89%1K
Income before tax
221.51%13.84M
-162.31%-56.82M
-786.54%-238.71M
-3,608.62%-196.66M
-9.59%-9M
-232.39%-11.39M
-175.28%-21.66M
457.68%34.77M
-54.71%5.61M
-297.58%-8.21M
Income tax
-3,019.87%-19M
-6,497.22%-19M
0
-103.81%-609K
-308.70%-288K
-102.03%-321K
Net income
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
Net income continuous Operations
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
Minority interest income
Net income attributable to the parent company
221.51%13.84M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
Preferred stock dividends
Other preferred stock dividends
4.21M
0
Net income attributable to common stockholders
184.55%9.63M
-162.31%-56.82M
-721.02%-219.71M
-3,114.73%-177.66M
-14.05%-9M
-232.39%-11.39M
-175.28%-21.66M
237.73%35.38M
-51.85%5.89M
55.89%-7.89M
Basic earnings per share
126.01%0.58
-147.64%-10.5
-791.67%-49.8
-4,733.33%-41.7
-20.00%-1.8
-223.89%-2.23
-161.45%-4.24
209.09%7.2
-70.00%0.9
68.75%-1.5
Diluted earnings per share
124.22%0.54
-147.64%-10.5
-1,760.00%-49.8
-2,680.00%-41.7
-20.00%-1.8
-223.89%-2.23
-276.67%-4.24
145.45%3
-266.67%-1.5
68.75%-1.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 537.17%33.45M-1.65%5.84M-76.53%26M-50.78%8.27M-68.37%6.55M-86.63%5.25M-82.53%5.94M30.21%110.78M-43.90%16.8M-15.22%20.71M
Operating revenue 537.17%33.45M-1.65%5.84M-76.53%26M-50.78%8.27M-68.37%6.55M-86.63%5.25M-82.53%5.94M30.21%110.78M-43.90%16.8M-15.22%20.71M
Cost of revenue
Gross profit
Operating expense -17.58%19.69M-21.10%19.19M16.81%112.42M76.34%44.6M-12.07%19.62M-6.00%23.89M4.71%24.32M7.32%96.24M-2.20%25.29M-15.48%22.31M
Selling and administrative expenses 15.10%7.03M65.94%9.45M70.07%40.58M250.52%22.17M14.63%6.61M-2.02%6.11M2.85%5.7M13.97%23.86M14.13%6.32M5.97%5.77M
-General and administrative expense 15.10%7.03M65.94%9.45M70.07%40.58M250.52%22.17M14.63%6.61M-2.02%6.11M2.85%5.7M13.97%23.86M14.13%6.32M5.97%5.77M
Research and development costs -28.80%12.66M-47.71%9.74M-0.74%71.84M18.26%22.43M-21.39%13M-7.30%17.78M5.29%18.62M5.30%72.38M-6.65%18.97M-21.06%16.54M
Operating profit 173.81%13.76M27.38%-13.35M-694.41%-86.42M-327.64%-36.33M-717.07%-13.07M-234.47%-18.64M-270.62%-18.38M416.25%14.54M-308.34%-8.5M18.79%-1.6M
Net non-operating interest income expense 006.53%-2.83M0-58.73%-1.27M-5.17%-752K-14.29%-808K-6.58%-3.03M-13.50%-807K-12.80%-802K
Non-operating interest expense --0--0-6.53%2.83M--058.73%1.27M5.17%752K14.29%808K6.58%3.03M13.50%807K12.80%802K
Other net income (expense) -99.01%79K-1,657.32%-43.48M-742.48%-149.46M-1,175.44%-160.33M191.79%5.34M276.12%8M-113.22%-2.47M1,120.31%23.26M65.46%14.91M-1,046.74%-5.81M
Gain on sale of security -134.97%-2.71M-71.64%-4.68M-674.94%-131.85M-1,063.58%-141.96M187.43%5.08M270.73%7.76M-114.71%-2.73M1,099.26%22.93M63.52%14.73M-1,060.99%-5.81M
Special income (charges) --2.5M---39.3M---18.3M----------0--0--0--------
-Less:Restructuring and merger&acquisition ---2.5M--39.3M--18.3M----------0--0--0--------
Other non- operating income (expenses) 19.18%292K99.22%508K109.39%691K-135.43%-62K25,200.00%253K--245K65.58%255K2,100.00%330K--175K-88.89%1K
Income before tax 221.51%13.84M-162.31%-56.82M-786.54%-238.71M-3,608.62%-196.66M-9.59%-9M-232.39%-11.39M-175.28%-21.66M457.68%34.77M-54.71%5.61M-297.58%-8.21M
Income tax -3,019.87%-19M-6,497.22%-19M0-103.81%-609K-308.70%-288K-102.03%-321K
Net income 221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M
Net income continuous Operations 221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M
Minority interest income
Net income attributable to the parent company 221.51%13.84M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M
Preferred stock dividends
Other preferred stock dividends 4.21M0
Net income attributable to common stockholders 184.55%9.63M-162.31%-56.82M-721.02%-219.71M-3,114.73%-177.66M-14.05%-9M-232.39%-11.39M-175.28%-21.66M237.73%35.38M-51.85%5.89M55.89%-7.89M
Basic earnings per share 126.01%0.58-147.64%-10.5-791.67%-49.8-4,733.33%-41.7-20.00%-1.8-223.89%-2.23-161.45%-4.24209.09%7.2-70.00%0.968.75%-1.5
Diluted earnings per share 124.22%0.54-147.64%-10.5-1,760.00%-49.8-2,680.00%-41.7-20.00%-1.8-223.89%-2.23-276.67%-4.24145.45%3-266.67%-1.568.75%-1.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data